Use of Freestyle Libre 2.0 in children with type 1 diabetes mellitus and elevated HbA<sub>1c</sub>: Extension phase results after a 12-week randomized controlled trial.

Diabet Med · 2025 · PMC12006559 · PMID 39658881

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

did not reach statistical significancep = 0.09so close (0.05 < p ≤ 0.1)

In the Control/isCGM group, TBR70 decreased by 8.2%, 95%CI: [3.2 to 13.1] % from 10.0 ± 8.1% to 3.2 ± 3.0% ( p = 0.004); TBR54 decreased from 3.7 ± 4.0% to 0.3 ± 0.5% yet did not reach statistical significance ( p = 0.09).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Use of Freestyle Libre 2.0 in children with type 1 diabetes mellitus and elevated HbA&lt;sub&gt;1c&lt;/sub&gt;: Extension phase results after a 12-week randomized controlled trial.

The sentences

Use of Freestyle Libre 2.0 in children with type 1 diabetes mellitus and elevated HbA<sub>1c</sub>: Extension phase results after a 12-week randomized controlled trial.